Association between blood pressure control and risk of recurrent intracerebral hemorrhage

JAMA - Journal of the American Medical Association

Volumn 314, Issue 9, 2015, Pages 904-912

  Biffi, Alessandro ^a,b   Anderson, Christopher D ^a,b   Battey, Thomas W K ^a,b   Ayres, Alison M ^a   Greenberg, Steven M ^a   Viswanathan, Anand ^a   Rosand, Jonathan ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREHYPERTENSION; PRIORITY JOURNAL; SELF REPORT; STAGING; SURVIVOR; SYSTOLIC BLOOD PRESSURE; CEREBRAL HEMORRHAGE; COMPLICATION; ETHNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PATHOLOGY; PROCEDURES; RECURRENT DISEASE; RISK; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA; TIME;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RISK; SECONDARY PREVENTION; STATISTICS, NONPARAMETRIC; SURVIVORS; TIME FACTORS;

EID: 84940759682     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.10082     Document Type: Article

References (20)

1. Samarasekera N, Smith C, Al-Shahi Salman R. The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2012;83(3):275-281.
2. Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry.2014;85(6):660-667.
3. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693-698.
4. Broderick J, Connolly S, Feldmann E, et al American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation.2007;116(16):e391-e413.
5. Arima H, Tzourio C, Anderson C, et al PROGRESS Collaborative Group. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke. 2010;41(2):394-396.
6. Arima H, Chalmers J, Woodward M, et al PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24(6):1201-1208.
7. Arima H, Anderson C, Omae T, et al PROGRESS Collaborative Group. Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. J Neurol Neurosurg Psychiatry. 2014;85(11):1284-1285.
8. Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. WhiteHouse.gov website. http://www.whitehouse.gov/omb/fedreg-1997standards. October 30, 1997. Accessed July 30, 2015.
9. Biffi A, Sonni A, Anderson CD, et al International Stroke Genetics Consortium. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68(6):934-943.
10. Chobanian AV, Bakris GL, Black HR, et al Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
11. Badjatia N, Rosand J. Intracerebral hemorrhage. Neurologist. 2005;11(6):311-324.
12. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
13. Zahuranec DB, Wing JJ, Edwards DF, et al. Poor long-term blood pressure control after intracerebral hemorrhage. Stroke. 2012;43(10):2580-2585.
14. Zhao W, Katzmarzyk PT, Horswell R, et al. Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care. 2013;36(10):3287-3296.
15. Hyman DJ, Taffet GE. Blood pressure control in the elderly: can you have too much of a good thing? Curr Hypertens Rep. 2009;11(5):337-342.
16. Taylor BC, Wilt TJ, Welch HG. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of "normal." J Gen Intern Med. 2011;26(7):685-690.
17. Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000;31(10):2307-2313.
18. Kovesdy CP, Lu JL, Molnar MZ, et al. Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med. 2014;174(9):1442-1449.
19. Moran AE, Odden MC, Thanataveerat A, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med.2015;372(5):447-455.
20. Liu W, Liu R, Sun W, et al CASISP Study Group. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke. 2012;43(11):2916-2922.